newsfilter
← Latest News
Business Wire·

Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference